— Know what they know.
Not Investment Advice
Also trades as: SBS.DE (XETRA) · $vol 0M · 0RAR.L (LSE) · $vol 0M

STSEY OTC

Stratec SE
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +8.0% 1Y: -17.8% 3Y: -78.5% 5Y: -78.1%
$5.51
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 47 · $1.7B mcap · 33M float · 0.0003% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.7B
52W Range5-6.7
Volume100
Avg Volume87
Beta0.81
Dividend$0.14
Analyst Ratings
No analyst coverage
Company Info
CEOMarcus Wolfinger
Employees1,403
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-05-13
Gewerbestrasse 37
Birkenfeld, RP 75217
DE
49 7082 7916 0
About Stratec SE

Stratec SE, an international company with various subsidiaries, focuses on developing and manufacturing automated instruments and sophisticated solutions for the in-vitro diagnostics and life sciences industries. Its commercial reach extends across Germany, the broader European Union, and other global regions. The company's operations are divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation division designs and produces advanced automated analyzer systems, including necessary replacement parts and supplies, serving customers in clinical diagnostics and biotechnology. The Diatron segment delivers a suite of systems, individual components, consumables, and diagnostic tests, particularly for low-throughput applications in hematology and clinical chemistry. Furthermore, the Smart Consumables division is dedicated to creating and manufacturing innovative consumables tailored for diagnostics, life sciences, and medical technology applications. Originally known as STRATEC Biomedical AG, the company rebranded to Stratec SE in December 2018. Founded in 1979, its main corporate office is situated in Birkenfeld, Germany.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms